EUVIMEDEUVIMED entdecken
Open Access

Adverse Pregnancy Outcomes and Future Metabolic Syndrome

Deborah B Ehrenthal, Rebecca B McNeil, Emma G Crenshaw, C Noel Bairey Merz, William A Grobman, Corette B Parker, Philip Greenland, Victoria L Pemberton, Phyllis C Zee, Christina M Scifres, LuAnn Polito, George Saade

Journal of Women's Health · 2023

DOI: 10.1089/jwh.2023.0026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Women's Health, 2023. Verfasst von Deborah B Ehrenthal und 11 weiteren Autor:innen. Beteiligte Einrichtung: Social Science Research Institute and Department of Biobehavioral Health, The Pennsylvania State University, University Park, Pennsylvania, USA. Hauptthemen laut MEDLINE: Metabolic Syndrome, Premature Birth, Diabetes, Gestational, Pre-Eclampsia. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIAID NIH HHS, NICHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Metabolic syndrome (MetS) is associated with a history of gestational diabetes (GDM), hypertensive disorders of pregnancy (HDP), and preterm birth (PTB), but it is unclear whether this association is due to the pregnancy complication(s) or prepregnancy/early pregnancy confounders. The study examines the association of GDM, HDP, and PTB with MetS 2-7 years later, independent of early pregnancy factors. Materials and Methods: Large, diverse cohort of nulliparous pregnant people with singleton gestations enrolled during their first trimester and who attended a follow-up study visit 2-7 years after delivery. The longitudinal cohort was recruited from eight medical centers across the United States. Using standardized protocols, anthropometry, biospecimens, and surveys were collected at study visits and pregnancy outcomes were abstracted from medical records. We estimated the relative risk of prevalent MetS at the follow-up study visit for participants with GDM, HDP, or PTB (vs. no complications), adjusting for early pregnancy age, body mass index, self-reported race/ethnicity, insurance type, and smoking status.

Results

Of 4,402 participants, 738 (16.8%) had MetS at follow-up: 13.1% (441/3,365) among those with no complications, and 27.9% (290/1,002) among those with complications. MetS occurred in 39.0% of GDM (73/187, adjusted relative risk [aRR] = 1.75; 95% confidence interval [CI] 1.42-2.16); 29.2% of HDP (176/603, aRR = 1.49; 95% CI 1.27-1.75); and 29.7% of PTB (113/380, aRR = 1.78; 95% CI 1.49-2.12). Those who had both HDP and PTB (n = 113) had an aRR = 1.95 (95% CI 1.50-2.54).

Conclusions

People whose pregnancies were complicated by GDM, HDP, or PTB are at a higher risk of MetS within 2-7 years after delivery, independent of early pregnancy risk factors. The highest MetS risk follows pregnancies complicated by both HDP and PTB.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metabolic SyndromePremature BirthDiabetes, GestationalPre-EclampsiaHypertension, Pregnancy-InducedPregnancyFemaleInfant, NewbornHumansPregnancy OutcomeFollow-Up StudiesRisk Factors

Stichwörter der Autor:innen

cohort studiesmetabolic syndromepregnancy complications

Autor:innen und Institutionen

  • Social Science Research Institute and Department of Biobehavioral Health, The Pennsylvania State University, University Park, Pennsylvania, USA.
  • RTI International, Research Triangle Park, North Carolina, USA.
  • Department of Biostatistics, Harvard University, Boston, Massachusetts, USA.
  • Barbra Streisand Women's Heart Center, Cedars-Sinai Smidt Heart Institute, Los Angeles, California, USA.
  • Department of Obstetrics and Gynecology, The Ohio State University, Columbus, Ohio, USA.
  • Department of Cardiology and Preventive Medicine, Northwestern University, Chicago, Illinois, USA.

Förderung

  • NHLBI NIH HHS
  • NIAID NIH HHS
  • NICHD NIH HHS
  • NCATS NIH HHS

Zitieren

APA

Ehrenthal, D. B., McNeil, R. B., Crenshaw, E. G., Bairey Merz, C. N., Grobman, W. A., Parker, C. B., Greenland, P., Pemberton, V. L., Zee, P. C., Scifres, C. M., Polito, L., & Saade, G. (2023). Adverse Pregnancy Outcomes and Future Metabolic Syndrome. Journal of Women's Health. https://doi.org/10.1089/jwh.2023.0026

Vancouver

Ehrenthal DB, McNeil RB, Crenshaw EG, Bairey Merz CN, Grobman WA, Parker CB, et al. Adverse Pregnancy Outcomes and Future Metabolic Syndrome. Journal of Women's Health. 2023. doi:10.1089/jwh.2023.0026

BibTeX
@article{Ehrenthal2023,
  author = {Ehrenthal, Deborah B and McNeil, Rebecca B and Crenshaw, Emma G and Bairey Merz, C Noel and Grobman, William A and Parker, Corette B and Greenland, Philip and Pemberton, Victoria L and Zee, Phyllis C and Scifres, Christina M and Polito, LuAnn and Saade, George},
  title = {Adverse Pregnancy Outcomes and Future Metabolic Syndrome},
  journal = {Journal of Women's Health},
  year = {2023},
  doi = {10.1089/jwh.2023.0026}
}
Kostenlos starten →